#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biliary neoplasm Transitional cell carcinoma Prophylaxis against transplant rejection Philadelphia chromosome positive Kaposi's sarcoma Crohn's disease Malignant glioma Erythema multiforme Neuroendocrine carcinoma metastatic Vernal keratoconjunctivitis Extraskeletal ossification Progressive supranuclear palsy Myocarditis Hodgkin's disease recurrent Breast cancer More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Basic Information Netherton’s syndrome – Life with Disease Primary hyperoxaluria – Basic Information Andersen-Tawil syndrome – Trials in Disease Hairy cell leukaemia – Treatment Mucous membrane pemphigoid Thrombotic thrombocytopenic purpura – Basic Information Mantle cell lymphoma stage IV – Treatment Advanced systemic mastocytosis – Trials in Disease Glycogen storage disease type II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RLY-2608 HALOBETASOL PROPIONATE Resatorvid Sar-443579 Siponimod Fumaric Acid SEPOFARSEN Gsk3858279 Arginine Anastrozole Aspartic Acid Op-1250 Salmeterol Cetuximab Histamine Dihydrochloride Coffee Charcoal Mexiletine Hydrochloride Ladarixin Gefitinib Zongertinib Sar444656 More therapies…

    Learn about Your Condition

    Blood disorder Multiple sclerosis relapse Foetal growth restriction HER2 positive breast cancer Arterial disorder Ureteric cancer Transplantation complication Gastrointestinal disorder Nodal osteoarthritis Skin angiosarcoma Blood iron increased Hypochromic anaemia Infertility male Varicella Lymphangioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Pre-operative Capecitabine, Oxaliplatin, Docetaxel, and Atezolizumab for Patients with Resectable Gastric or Gastro-esophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Atezolizumab
    • Capecitabine
    • Docetaxel
    The Netherlands

  • Study on EXL01 with Nivolumab and FOLFOX for First-Line Treatment in Patients with PD-L1 CPS ≥5 Metastatic Gastric Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Exl01
    • Fluorouracil Sodium
    France

  • Study of Elafibranor for Adults with Primary Biliary Cholangitis

    Recruiting

    3 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Elafibranor
    Belgium Bulgaria Czechia Denmark France Greece +8

  • Study on Treating Perianal Fistulas Using Adipose Derived Regenerative Cells, Metronidazole, and Cefuroxime for Patients with Complex Perianal Fistulas

    Recruiting

    2 1 1
    Investigated Diseases:
    • Anal fistula
    Investigated Drugs:
    • Adrc
    • Adrc001
    Denmark

  • Study on the Effectiveness of Ozanimod for Children with Moderate to Severe Ulcerative Colitis Not Responding to Usual Treatment

    Recruiting

    4 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Ozanimod
    Belgium France Germany Poland Spain

  • Study on Sufentanil’s Effect on Chronic Pain After Non-Major Abdominal Surgery for Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Sufentanil
    France
Previous Page
1 … 28 29 30 31 32 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!